BioSpace News Archive

Assertio Holdings, Inc. announced that it will release fourth quarter and full year 2021 financial results on Wednesday, March 9, 2022, before the open of markets.

Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), today announced that among the large and rapidly growing stem cell therapeutics sector, the Company’s cancer stem cell technology, PRP, offers renewed hope to achieve a total victory in the fight against cancer.

Statera Biopharma, Inc. announced submission to the U.S. Food and Drug Administration of its pilot study protocol for STAT-205 treatment of post-acute COVID-19.

Home care medical devices are intentional for use in any location outside a professional health care facility.

Ewing sarcoma is a destructive sarcoma of the soft tissue and the bones, which can occur at any age with the maximum rate of incidence recorded in young adults and adolescents.

Surgical staplers are specialized medical devices used in surgeries in place of sutures to connect or remove parts of the lungs or the bowels to close skin wounds.

Nicox SA, an international ophthalmology company, and Fera Pharmaceuticals, a privately-held, U.S. specialty pharmaceutical company, announced that the United States Food and Drug Administration has granted Orphan Drug Designation for naproxcinod for the treatment of sickle cell disease, which affects an estimated 100,000 Americans.

Prokarium announced it exercised its option with Lausanne University Hospital for an exclusive, worldwide license for the use of Salmonella immunotherapy in the treatment of bladder cancer.

Arcutis Biotherapeutics, Inc., a late-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, announced that Arcutis management will participate in an upcoming investor conference.

Opthea Limited, a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, is pleased to announce the appointment of Dr. Joel Naor as Chief Medical Officer, effective 1 March 2022.